|[January 14, 2013]
PharMerica Corporation Names Patrick G. LePore to Its Board of Directors
LOUISVILLE, Ky. --(Business Wire)--
PharMerica Corporation (NYSE: PMC), a national provider of institutional
pharmacy, specialty infusion and hospital pharmacy management services,
today announced that it has appointed Patrick G. LePore to the Company's
Board of Directors.
Since 2007, Mr. LePore has served as the Chairman of the Board of Par
Pharmaceutical Companies, Inc., where he also served as Chief Executive
Officer until the company's acquisition by private equity investor TPG
in September 2012. Prior to joining Par Pharmaceutical, he was President
of Cardinal Health, Inc.'s healthcare marketing group. Mr. LePore is a
trustee of Villanova University, where he earned a B.A. degree. Mr.
LePore earned his MBA degree from Fairleigh Dickinson University.
Commenting on the addition of Mr. LePore to the Board, Geoffrey G.
Meyers, PharMerica's Chairman of the Board, said, "Mr. LePore is an
excellent addition to our Board. His management experience in the
pharmaceutical industry brings considerable value to our company, and we
look forward to his insight and contributions."
PharMerica Corporation is a leading institutional pharmacy, specialty
infusion and hospital pharmacy management services company servicing
healthcare facilities in the United States. PharMerica operates
pharmacies in 45 state. PharMerica's customers are institutional
healthcare providers, such as nursing centers, assisted living
facilities, hospitals and other long-term care providers. In addition,
the Company provides specialty infusion pharmaceuticals to patients in a
home setting. The Company also provides pharmacy management services to
long-term care hospitals.
This press release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, which
reflect the Company's current estimates, expectations and projections
about its future results, performance, prospects and opportunities. Forward-looking
statements include statements that are not historical facts and can be
identified by forward-looking words such as "anticipate," "believe,"
"could," "estimate," "expect," "intend," "plan," "may," "should,"
"will," "would," "project" and similar expressions. These
forward-looking statements are based upon information currently
available to us and are subject to a number of risks, uncertainties and
other factors that could cause the Company's actual results,
performance, prospects or opportunities to differ materially from those
expressed in, or implied by, these forward-looking statements. Important
factors that could cause the Company's actual results to differ
materially from the results referred to in the forward-looking
statements we make in this press release are included in the Risk
Factors section set forth in the Company's Annual Report on Form 10-K
filed with the SEC (News - Alert) and in other reports, including Quarterly Reports on
Form 10-Q filed with the SEC by the Company.
You are cautioned not to place undue reliance on any forward-looking
statements, all of which speak only as of the date of this press release.
Except as required by law, we undertake no obligation to publicly
update or release any revisions to these forward-looking statements to
reflect any events or circumstances after the date of this press release
or to reflect the occurrence of unanticipated events. All
subsequent written and oral forward-looking statements attributable to
us or any person acting on the Company's behalf are expressly qualified
in their entirety by the cautionary statements contained or referred to
in this press release and in the Risk Factors section set forth in the
Company's Annual Report on Form 10-K filed with the SEC and in other
reports filed with the SEC by the Company.
[ Back To Financial Technology's Homepage ]